These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18570285)

  • 1. [5-Alpha reductase inhibitors--benign prostatic hypertrophy and much more].
    Holzgrabe U; Bennack E
    Pharm Unserer Zeit; 2008; 37(4):310-4. PubMed ID: 18570285
    [No Abstract]   [Full Text] [Related]  

  • 2. Finasteride in benign prostatic hyperplasia.
    Wysowski DK; Farinas E
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological options in the treatment of benign prostatic hyperplasia.
    Kenny B; Ballard S; Blagg J; Fox D
    J Med Chem; 1997 Apr; 40(9):1293-315. PubMed ID: 9135028
    [No Abstract]   [Full Text] [Related]  

  • 4. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia--review of treatment options.
    Oehlke KJ; Branaugh ML
    S D Med; 2009 May; 62(5):202-3. PubMed ID: 19489345
    [No Abstract]   [Full Text] [Related]  

  • 6. Breakthrough treatment for prostate enlargement.
    Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dutasteride--an inhibitor of 5alpha-reductase of type I and II--in the treatment of patients with prostatic adenoma. What is the latest news?].
    Grigor'ev ME; Konorev VA
    Urologiia; 2007; (6):90, 92-5. PubMed ID: 18652016
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medical therapy of benign prostatic hyperplasia].
    Altarac S
    Lijec Vjesn; 2005; 127(11-12):316-23. PubMed ID: 16583940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new take on prostate drugs.
    Johns Hopkins Med Lett Health After 50; 1998 Apr; 10(2):1-2. PubMed ID: 9552801
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel in vitro model to screen steroid 5 alpha-reductase inhibitors against benign prostatic hyperplasia.
    Sun ZY; Tu ZH
    Methods Find Exp Clin Pharmacol; 1998 May; 20(4):283-7. PubMed ID: 9658376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propecia and Rogaine Extra Strength for alopecia.
    Med Lett Drugs Ther; 1998 Feb; 40(1021):25-7. PubMed ID: 9505960
    [No Abstract]   [Full Text] [Related]  

  • 12. Waxing and waning gynecomastia: an indication of noncompliant use of prescribed medication.
    Miller JA; Pramanik B; Gilhooly P
    South Med J; 1999 Jun; 92(6):615-7. PubMed ID: 10372857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open to debate. The motion: prevention of prostate cancer with a 5alpha-reductase inhibitor is feasible.
    Roehrborn CG; Lotan Y; Tubaro A; de Nunzio C
    Eur Urol; 2006 Feb; 49(2):396-400. PubMed ID: 16455190
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gynecomastia and finasteride].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2001 May; 128(5):691. PubMed ID: 11427816
    [No Abstract]   [Full Text] [Related]  

  • 15. Finasteride (Propecia) and the promotion of high-grade prostate cancer.
    Pitts WR
    Arch Dermatol; 2004 Jul; 140(7):885-6. PubMed ID: 15262708
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Chir (Paris); 1994 Oct; 131(10):445-9. PubMed ID: 7532181
    [No Abstract]   [Full Text] [Related]  

  • 17. 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.
    Dörsam J; Altwein J
    Prostate Cancer Prostatic Dis; 2009; 12(2):130-6. PubMed ID: 19030020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme inhibition in the drug therapy of benign prostatic hyperplasia].
    Drsata J
    Cas Lek Cesk; 2002 Oct; 141(20):630-5. PubMed ID: 12515038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current state of the surgical treatment of benign prostatic hypertrophy].
    Pagano F
    J Urol (Paris); 1993; 99(6):362-3. PubMed ID: 7516392
    [No Abstract]   [Full Text] [Related]  

  • 20. Female androgenetic alopecia treated by finasteride: a case forward.
    Valsecchi R; Leghissa P; Riva M
    Acta Derm Venereol; 2004; 84(6):488-9. PubMed ID: 15844649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.